Edition:
United States

Reata Pharmaceuticals Inc (RETA.OQ)

RETA.OQ on NASDAQ Stock Exchange Global Market

59.47USD
14 Dec 2018
Change (% chg)

$-1.96 (-3.19%)
Prev Close
$61.43
Open
$60.66
Day's High
$61.51
Day's Low
$59.44
Volume
75,418
Avg. Vol
97,968
52-wk High
$99.26
52-wk Low
$19.32

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 5.18 -1.074
Jun '18 7.57 -1.078
Mar '18 32.39 0.153
FY 2017 Dec '17 9.96 -0.638
Sep '17 12.56 -0.495
Jun '17 12.81 -0.518
Mar '17 12.73 -0.318
FY 2016 Dec '16 12.50 -0.185
Sep '16 12.55 -0.040
Jun '16 12.37 -0.050
Mar '16 12.44 -0.013
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 6 6.07 7.60 5.00 9.77
Quarter Ending Mar-19 2 6.13 7.50 4.77 7.05
Year Ending Dec-18 6 51.09 52.74 49.45 47.02
Year Ending Dec-19 6 28.21 45.00 19.06 53.17
Earnings (per share)
Quarter Ending Dec-18 7 -1.07 -0.95 -1.21 -0.52
Quarter Ending Mar-19 4 -1.07 -1.00 -1.12 -0.67
Year Ending Dec-18 7 -3.11 -3.01 -3.21 -2.36
Year Ending Dec-19 7 -4.52 -3.77 -5.30 -3.32
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 95.96 30.88
P/E High - Last 5 Yrs. -- 287.89 46.69
P/E Low - Last 5 Yrs. -- 90.15 25.78
Beta -- 0.66 0.95
Price to Sales (TTM) 32.67 242.95 21.76
Price to Book (MRQ) 47.91 18.87 4.53
Price to Tangible Book (MRQ) 47.94 22.13 11.76
Price to Cash Flow (TTM) -- 54.67 22.24
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.39 1.60
Dividend Yield - 5 Year Avg -- 0.20 1.42
Dividend 5 Year Growth Rate -- 3.31 -8.76
Payout Ratio(TTM) -- 6.79 44.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -58.79 156.34 6.54
Sales (TTM) vs TTM 1 Yr. Ago 8.91 61.53 5.26
Sales - 5 Yr. Growth Rate -- 24.06 7.59
EPS (MRQ) vs Qtr. 1 Yr. Ago -116.85 196.06 22.50
EPS (TTM) vs TTM 1 Yr. Ago -80.80 -- --
EPS - 5 Yr. Growth Rate -- 23.46 7.64
Capital Spending - 5 Yr. Growth Rate -- 37.07 8.38

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 3.57 2.63
Current Ratio (MRQ) 6.04 6.87 3.68
LT Debt to Equity (MRQ) 210.10 16.70 9.53
Total Debt to Equity (MRQ) 210.10 21.89 13.39
Interest Coverage (TTM) -68.83 -289.65 33.85

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 31.33 50.91
Gross Margin - 5 Yr. Avg. -- 47.59 52.22
EBITD Margin (TTM) -123.54 -- --
EBITD - 5 Yr. Avg -- -141.70 16.27
Operating Margin (TTM) -126.11 -1,638.83 -15.11
Operating Margin - 5 Yr. Avg. -- -155.53 11.89
Pre-Tax Margin (TTM) -129.99 -1,574.14 -13.67
Pre-Tax Margin - 5 Yr. Avg. -- -157.11 12.22
Net Profit Margin (TTM) -130.02 -1,572.92 -17.11
Net Profit Margin - 5 Yr. Avg. -- -158.05 8.44
Effective Tax Rate (TTM) -- 15.93 21.73
Effective Tax Rate - 5 Yr. Avg. -- 19.64 24.41

Efficiency

  Company industry sector
Revenue/Employee (TTM) 592,495 28,103,806 878,349,382
Net Income/Employee (TTM) -770,344 -3,710,889 102,474,711
Receivable Turnover (TTM) -- 9.19 5.49
Inventory Turnover (TTM) -- 2.64 3.99
Asset Turnover (TTM) 0.20 0.46 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -26.41 0.35 11.06
Return on Assets - 5 Yr. Avg. -- 2.90 11.85
Return on Investment (TTM) -33.32 0.60 13.80
Return on Investment - 5 Yr. Avg. -- 2.87 15.17
Return on Equity (TTM) -- -2.18 15.29
Return on Equity - 5 Yr. Avg. -- -0.88 16.29
  1 Year 3 Year 5 Year
Sales % -3.61 -2.56 --
EPS (TTM) % -533.88 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Reata Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 7.11 7.13 78 99
13 Week -27.53 -21.71 36 94
26 Week 77.16 77.66 96 96
52 Week 137.53 130.38 95 98
YTD 113.88 113.19 95 94
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 67.97%
# of Holders: 173
Total Shares Held: 16,306,983
3 Mo. Net Change: 3,570,242
# New Positions: 44
# Closed Positions: 11
# Increased Positions: 110
# Reduced Positions: 51
# Net Buyers: 59
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.